The Value of Transvaginal Ultrasonography in the Endometrial Evaluation of Breast Cancer Patients Using Tamoxifen

被引:7
|
作者
Kazerooni, Talieh [1 ]
Ghaffarpasand, Fariborz [3 ]
Mosalaei, Ahmad [2 ]
Kazeroonip, Yasaman [1 ]
机构
[1] Shiraz Univ Med Sci, Dept Obstet & Gynecol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Nucl Med & Radiotherapy, Shiraz, Iran
[3] Fasa Univ Med Sci, Student Res Comm, Fasa, Iran
关键词
Transvaginal ultrasonography; Tamoxifen; Breast cancer; Endometrial biopsy; Endometrial atrophy; SURGICAL ADJUVANT BREAST; POSTMENOPAUSAL WOMEN; RECEIVING TAMOXIFEN; HYSTEROSCOPY; TRIAL; SONOHYSTEROGRAPHY; SONOGRAPHY; PREVENTION; ULTRASOUND; THICKNESS;
D O I
10.1159/000285296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To estimate the value of transvaginal ultrasonography (TVU) in evaluating the endometrium in breast cancer patients on tamoxifen, and to investigate the relationship between TVU and histologic endometrial findings in these patients. Subjects and Methods: 107 breast cancer patients taking tamoxifen were included in this study. TVU was performed twice for each patient: prior to starting tamoxifen therapy and 1 year after taking tamoxifen. An endometrial thickness of 6 5 mm was considered abnormal. Endometrial biopsy was performed at the same time the 2nd TVU was done. The patients were divided into 2 groups: symptomatic (group A) and asymptomatic (group B), based on whether or not there was abnormal vaginal bleeding. Results: 31 patients (29%) were symptomatic, while the remaining 76 (71%) were asymptomatic. The endometrial thickness increased after 1 year of taking tamoxifen from 4.84 +/- 0.4 mm to 6.34 +/- 2.1 mm in group A and from 4.73 +/- 0.3 mm to 5.67 +/- 1.95 mm in group B (p>0.05). Endometrial biopsy revealed 77 (71.96%) atrophic endometria and 21 (19.62%) polyps. A comparison between the 2 groups showed a significant difference in patients with endometrial atrophy and atypical hyperplasia. Patients who had an endometrial thickness of 1 5 mm had a significantly higher prevalence of atypical hyperplasia ( p = 0.003) and polyps ( p = 0.041). The sensitivity, specificity, positive predictive and negative predictive values of TVU were 63.3, 28.57, 25.67 and 66.66%, respectively. Conclusion: Our study showed a discrepancy between TVU and endometrial biopsy findings, due to the specific histology of the endometrium in breast cancer patients using tamoxifen. Due to this discrepancy, TVU alone is not an effective screening test for endometrial pathology and its application alone might lead to an undesirably high frequency of invasive diagnostic procedures. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:222 / 227
页数:6
相关论文
共 50 条
  • [1] Transvaginal ultrasonography and endometrial changes in postmenopausal breast cancer patients receiving tamoxifen
    Dijkhuizen, FPHLJ
    Brolmann, HAM
    Oddens, BJJ
    Roumen, RMH
    Coebergh, JWW
    Heintz, APM
    [J]. MATURITAS, 1996, 25 (01) : 45 - 50
  • [2] Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment
    S Ciatto
    S Cecchini
    G Gervasi
    A Landini
    M Zappa
    E Crocetti
    [J]. British Journal of Cancer, 2003, 88 : 1175 - 1179
  • [3] Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment
    Ciatto, S
    Cecchini, S
    Gervasi, G
    Landini, A
    Zappa, M
    Crocetti, E
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 (08) : 1175 - 1179
  • [4] The value of transvaginal ultrasonography in the prediction of endometrial pathologies in asymptomatic postmenopausal breast cancer tamoxifen-treated patients
    Markovitch, O
    Tepper, R
    Fishman, A
    Shapira, J
    Aviram, R
    Cohen, I
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 456 - 462
  • [5] The value of transvaginal ultrasonography in predicting endometrial pathologies in asymptomatic, postmenopausal, tamoxifen-treated breast cancer patients
    不详
    [J]. EJC SUPPLEMENTS, 2004, 2 (09): : 107 - 107
  • [6] The endometrium in asymptomatic breast cancer patients on tamoxifen:: value of transvaginal ultrasonography with saline infusion and Doppler flow
    Develioglu, OH
    Omak, M
    Bilgin, T
    Esmer, A
    Tüfekçi, M
    [J]. GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 328 - 335
  • [7] Value of Transvaginal Ultrasonography in Patients with Metrorrhagia of Endometrial Origin
    del Vallea, Yolanda
    Lorente, Rosa M.
    Salazar, Francisco
    Alcaraza, M. Jose
    [J]. RADIOLOGIA, 2005, 47 (06): : 323 - 328
  • [8] Evaluation of endometrium by transvaginal ultrasonography and Doppler in tamoxifen-treated women with breast cancer
    Bezircioglu, I.
    Baloglu, A.
    Tarhan, M. O.
    Oziz, E.
    Yigit, S.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2012, 33 (03) : 295 - 299
  • [9] Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy
    McGonigle, KF
    Shaw, SL
    Vasilev, SA
    Odom-Maryon, T
    Roy, S
    Simpson, JF
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (06) : 1145 - 1150
  • [10] Transvaginal ultrasonography and hysterosonography to monitor endometrial effects in tamoxifen-treated patients
    Valenzano, M
    Bertelli, GF
    Costantini, S
    Corticelli, A
    Del Mastro, L
    Paoletti, R
    Garrone, O
    Rissone, R
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2001, 22 (06) : 441 - 444